Aripiprazole Orally Disintegrating Tablets 5mg (Suoqingning)

Aripiprazole Orally Disintegrating Tablets 5mg (Suoqingning)

$4.00

Suoqingning (Aripiprazole Orally Disintegrating Tablets) is a fast-dissolving formulation of aripiprazole, designed for research in psychopharmacology and neuropsychiatric disorders. Each box contains 60 tablets (5mg each), manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd.

EMI starting from $0.00/month - View Plans
Compare

Description

Aripiprazole is a dopamine D2 receptor partial agonist and serotonin 5-HT1A agonist, widely studied for its role in treating schizophrenia, bipolar disorder, and major depressive disorder. The orally disintegrating tablet (ODT) formulation allows for rapid systemic absorption, making it ideal for experimental designs that explore fast-onset antipsychotic activity.


Aripiprazole Orally Disintegrating Tablets Product Specifications

ParameterDetails
Product NameAripiprazole Orally Disintegrating Tablets
Brand NameSuoqingning (???)
Active IngredientAripiprazole
CAS Number129722-12-9
Molecular FormulaC23H27Cl2N3O2
Molecular Weight448.39 g/mol
FormulationOrally Disintegrating Tablet (ODT)
Strength5?mg per tablet
Pack Size60 tablets per box
Approval NumberH20213878 (NMPA, China)
Drug Code86904647001065
ManufacturerZhejiang Huahai Pharmaceutical Co., Ltd.
Product Barcode6958439002925
Storage ConditionsStore in a cool, dry place; avoid direct sunlight and moisture
Intended UseFor laboratory research purposes only

Aripiprazole Orally Disintegrating Tablets Mechanism of Action

Aripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at 5-HT2A receptors. Its unique pharmacodynamic profile makes it suitable for research in dopaminergic regulation, mood stabilization, and schizophrenia-related behaviors in animal and cellular models.


Research Applications

  • Psychiatric Disease Models
    Ideal for studying schizophrenia, bipolar disorder, and treatment-resistant depression.

  • Dopamine and Serotonin Pathway Analysis
    Used in receptor binding assays and signaling pathway exploration.

  • Oral Drug Delivery Studies
    Fast-dissolving formulation aids in pharmacokinetic modeling and bioavailability assessments.

  • Neurotransmitter Modulation Research
    Evaluates regulation of dopamine and serotonin in CNS experiments.


Handling & Storage

  • Handling: Use proper protective gear (gloves, lab coat) when handling tablets.

  • Storage: Store below 25?°C. Keep dry and protect from light.

  • Stability: Typically stable for 24–36 months in sealed original packaging.


Research-Use Disclaimer

This product is intended exclusively for laboratory research use. It is not approved for human consumption, clinical diagnosis, or therapeutic use. Improper use may pose health risks. Handle in compliance with your institution’s biosafety standards.

Additional information

Weight1 kg
Dimensions26 × 23 × 26 cm

Reviews

There are no reviews yet.

Be the first to review “Aripiprazole Orally Disintegrating Tablets 5mg (Suoqingning)”

Your email address will not be published. Required fields are marked *

Q1: What is the primary research use of Aripiprazole ODT?

A1: It is used for studies on schizophrenia, dopamine regulation, and receptor pharmacology.

Q2: Is this product suitable for human or veterinary use?

A2: No. This product is strictly for laboratory research only and not approved for therapeutic use.

Q3: Do you support bulk/wholesale orders?

A3: Yes, we offer flexible wholesale pricing and global shipping. MOQ available on request.

Q4: What kind of documentation is included?

A4: COA (Certificate of Analysis), SDS (Safety Data Sheet), and product specification sheets are available.

Q5: Can this formulation be used in oral absorption models?

A5: Yes, its ODT nature makes it ideal for rapid absorption and first-pass metabolism studies.


EMI Options

Select at least 2 products
to compare